2022

1. MDS-454 SF3B1 and DNMT3A Mutations Might Play a Role in Poor Prognosis and AML Progression in Patients With Isolated del(5q) MDS

   Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S316

2. Relevance of infections on the outcomes of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia treated with hypomethylating agents: a cohort study from the GESMD

   Therapeutic Advances in Hematology, Vol. 13